Browsing by 키워드 : Double-Blind Method
전체 결과 6건 중 1-6 번을 표시중입니다.
-
1
Article
Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
우세준
;
윤영희
;
Andras Papp
;
et al
2021
-
2
Article
Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
우세준
;
윤영희
;
Andras Papp
;
et al
2021
-
3
Article
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Josep M Llovet
;
Masatoshi Kudo
;
Philippe Merle
;
et al
2023
-
4
Article
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang
;
Li-Tzong Chen
;
Min-Hee Ryu
;
et al
2022
-
5
Article
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Thomas Powles
;
Piotr Tomczak
;
Se Hoon Park
;
et al
2022
-
6
Article
The efficacy and safety of BM-PHA for the correction of nasolabial folds: a multicenter, randomized, double-blind, split-face clinical trial
김범준
;
백승환
;
원종현
;
et al
2021